Ex-U.S. biotech executive fined for lying to auditors, charges dropped against CFO: SEC
NEW YORK (Reuters) - The former chief business officer of U.S. biotechnology company Osiris Therapeutics Inc has agreed to pay a ,000 civil penalty for lying to auditors, the Securities and Exchange Commission said on Thursday.
The SEC had alleged that Bobby Dwayne Montgomery prompted Osiris to book fake revenue and give false information to auditors. Montgomery agreed to a judgment that enjoins him from future violations of securities law, the SEC said in a statement.
"Our client is pleased to have resolved this matter on a no-admit no-deny basis, and looks forward to moving on with his life," said Stephen Crimmins, ...